Debevoise Advises Deutsche Bank as Financial Advisor to Signify Health in Its $8 Billion Sale to CVS Health

6 September 2022

Debevoise & Plimpton LLP is advising Deutsche Bank as financial advisor to Signify Health (NYSE: SGFY) in its $8 billion sale to CVS Health (NYSE: CVS). For more information, please see the company’s press release.

Signify Health is a leading health care platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. CVS Health is a leading health solutions company that helps people navigate the health care system and their personal health care by improving access, lowering costs and being a trusted partner for every meaningful moment of health.

The Debevoise team is led by M&A partner Andrew Bab and includes associate Alice Gu.